A clinical trial found that for hospitalized patients with severe depression, adding repeated ketamine infusions to standard care showed no significant benefit over a psychoactive placebo, suggesting the drug's antidepressant effects may be smaller than previously thought.
A new clinical trial has found that adding repeated intravenous ketamine infusions to standard care for hospitalized patients with serious depression did not provide a significant additional benefit. The study, which compared ketamine to a psychoacti... [8726 chars]